Although antibodies against PF4–heparin and PF4 bind to distinct epitopes on PF4, both types of antibodies cross-link platelet Fc receptors (FcγRIIA), inducing platelet activation and hypercoagulability (5, 6, 9, 24–32). Here, PF4 is linked to thrombophilia.